The ELISA and enzymatic techniques are the standards in neonatal screening. These techniques enable the detection of metabolic and endocrine diseases that may cause developmental delays, or even death, in infants. With early detection, prompt management can be implemented, thereby maximizing the newborn’s chances of growing and developing normally.
ZenTech markets nine kits using ELISA and enzyme techniques for the detection of eight diseases.
To cater for the needs of each type of laboratory, regardless of size, manual or automated kits are available.
The NEONATAL Biotinidase Screening Assay kit is an enzymatic test for biotinidase activity quantification. This test is intended for neonatal screening of holocarboxylase or biotinidase (BTD) deficiency and is performed using dried blood samples on 903 or 226 blotting paper.
The NEONATAL TSH Screening ELISA kit is an ELISA-type quantitative test for quantifying thyrotropin or thyroid stimulating hormone (TSH) from dried blood lab test samples on 903® or 226 blotting paper. This TSH test is for newborn baby screening for congenital hypothyroidism.
The NEONATAL TOTAL-T4 Screening ELISA kit is an ELISA-type quantitative hypothyroidism test used to quantify the totality of thyroxine (T4) contained in a test dried blood samples on 903® or 226 blotting paper. This test is for congenital hypothyroidism newborn screening.
The ELIZEN Neonatal 17-OHP Screening test is an ELISA-type quantitative test for newborn screening for congenital adrenal hyperplasia. It allows for the determination of the concentration of 17-hydroxyprogesterone (17-OHP) present in a sample of blood dried on 903® or 226 blotted type paper.
The NEONATAL G-6-PD Screening Assay is an enzymatic test in newborns for the quantification of glucose-6-phosphate dehydrogenase (G-6-PD) activity. This test is intended for neonatal screening of favism or glucose-6-phosphate dehydrogenase (G-6-PD) deficiency in newborns and is performed using dried blood samples on 903® or 226 blotting paper.
The NEONATAL Total Galactose Screening Assay is an enzymatic test used to quantify total galactose (galactose and galactose-1-phosphate) as part of neonatal screening blood test for galactosemia. This test is performed based on dried blood samples taken on 903® and 226 type blotted paper.
NEONATAL PKU Screening Assay is a quantitative enzyme assay used in phenylketonuria (PKU) newborn screening. It's a PKU test for newborns that quantifies an abnormal concentration of phenylalanine in dried blood samples on 903® or 226 blotting paper.
The NEONATAL PAP Screening ELISA is an ELISA-type quantitative test that allows determination of the concentration of pancreatitis-associated protein (PAP) in newborns. This second-line test is used as part of screening for cystic fibrosis (CF) in neonates, from blood samples dried on 903® or 226 type blotting paper.
NEONATAL MSUD Screening Assay is a quantitative enzymatic test that assays leukine, one of the 3 amino acids accumulated in maple syrup urine disease (MSUD) also known as ketoacidemia or branched-chain amino acids (BCAAs). This test is for maple syrup urine disease newborn screening, and is performed using dried blood samples on 903® or 226 type blotting paper.
The NEONATAL IRT Screening ELISA is an ELISA-type quantitative test that allows determination of the concentration of human immunoreactive trypsinogen (IRT). This test is for newborn screening of cystic fibrosis (CF) from blood samples dried on 903® and 226 type blotting paper.
